These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 8860324)

  • 21. Implementing Toxicity Testing in the 21st Century (TT21C): Making safety decisions using toxicity pathways, and progress in a prototype risk assessment.
    Adeleye Y; Andersen M; Clewell R; Davies M; Dent M; Edwards S; Fowler P; Malcomber S; Nicol B; Scott A; Scott S; Sun B; Westmoreland C; White A; Zhang Q; Carmichael PL
    Toxicology; 2015 Jun; 332():102-11. PubMed ID: 24582757
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neurobehavioral methods used in neurotoxicology.
    Tilson HA
    NIDA Res Monogr; 1993; 136():1-30; discussion 31-3. PubMed ID: 8289908
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quantalization of continuous data for benchmark dose estimation.
    Gaylor DW
    Regul Toxicol Pharmacol; 1996 Dec; 24(3):246-50. PubMed ID: 8975754
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Testing for cognitive function in animals in a regulatory context.
    Bushnell PJ
    Neurotoxicol Teratol; 2015; 52(Pt A):68-77. PubMed ID: 24815542
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human health screening level risk assessments of tertiary-butyl acetate (TBAC): calculated acute and chronic reference concentration (RfC) and Hazard Quotient (HQ) values based on toxicity and exposure scenario evaluations.
    Bus JS; Banton MI; Faber WD; Kirman CR; McGregor DB; Pourreau DB
    Crit Rev Toxicol; 2015 Feb; 45(2):142-71. PubMed ID: 25629921
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparing probabilistic and descriptive analyses of time-dose-toxicity relationship for determining no-observed-adverse-effect level in drug development.
    Glatard A; Berges A; Sahota T; Ambery C; Osborne J; Smith R; Hénin E; Chen C
    Toxicol Appl Pharmacol; 2015 Oct; 288(2):240-8. PubMed ID: 26232187
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Setting exposure standards: a decision process.
    Tilson HA; MacPhail RC; Crofton KM
    Environ Health Perspect; 1996 Apr; 104 Suppl 2(Suppl 2):401-5. PubMed ID: 9182048
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neurobehavioral assessment of mice following repeated oral exposures to domoic acid during prenatal development.
    Shiotani M; Cole TB; Hong S; Park JJY; Griffith WC; Burbacher TM; Workman T; Costa LG; Faustman EM
    Neurotoxicol Teratol; 2017 Nov; 64():8-19. PubMed ID: 28916171
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evolution and current status of neurotoxicity risk assessment.
    Tilson HA
    Drug Metab Rev; 1996; 28(1-2):121-39. PubMed ID: 8744593
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The IPCS Collaborative Study on Neurobehavioral Screening. I. Background and genesis.
    MacPhail RC; Tilson HA; Moser VC; Becking GC; Cuomo V; Frantík E; Kulig BM; Winneke G
    Neurotoxicology; 1997; 18(4):925-8. PubMed ID: 9457729
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Development of Higher Brain Function Tests in Rodents and Its Application to Neurotoxicity Assessment of Environmental Chemicals].
    Kakeyama M
    Nihon Eiseigaku Zasshi; 2015; 70(2):120-6. PubMed ID: 25994343
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of aldicarb and methamidophos neurotoxicity at different ages in the rat: behavioral and biochemical parameters.
    Moser VC
    Toxicol Appl Pharmacol; 1999 Jun; 157(2):94-106. PubMed ID: 10366542
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The IPCS Collaborative Study on Neurobehavioral Screening Methods: VII. Summary and conclusions.
    Tilson HA; MacPhail RC; Moser VC; Becking GC; Cuomo V; Frantík E; Kulig BM; Winneke G
    Neurotoxicology; 1997; 18(4):1065-9. PubMed ID: 9457735
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Behavioral toxicology and risk assessment.
    Annau Z
    Neurotoxicol Teratol; 1990; 12(5):547-51. PubMed ID: 2247046
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Functional assays for neurotoxicity testing.
    Moser VC
    Toxicol Pathol; 2011 Jan; 39(1):36-45. PubMed ID: 21075917
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neurobehavioral assessment: a survey of use and value in safety assessment studies.
    Middaugh LD; Dow-Edwards D; Li AA; Sandler JD; Seed J; Sheets LP; Shuey DL; Slikker W; Weisenburger WP; Wise LD; Selwyn MR
    Toxicol Sci; 2003 Dec; 76(2):250-61. PubMed ID: 12915715
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assessment of learning, memory and attention in developmental neurotoxicity regulatory studies: Introduction.
    Makris SL; Vorhees CV
    Neurotoxicol Teratol; 2015; 52(Pt A):62-7. PubMed ID: 26049062
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Assessment of neuroanatomical and behavioural effects of in ovo methylmercury exposure in zebra finches (Taeniopygia guttata).
    Yu MS; Eng ML; Williams TD; Guigueno MF; Elliott JE
    Neurotoxicology; 2017 Mar; 59():33-39. PubMed ID: 28077286
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neurobehavioral screening in rodents.
    Moser VC
    Curr Protoc Toxicol; 2001 May; Chapter 11():Unit11.2. PubMed ID: 20957639
    [TBL] [Abstract][Full Text] [Related]  

  • 40. More ecological ERA: incorporating natural environmental factors and animal behavior.
    Bednarska AJ; Jevtić DM; Laskowski R
    Integr Environ Assess Manag; 2013 Jul; 9(3):e39-46. PubMed ID: 23625590
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.